Magnus Financial Group LLC Akebia Therapeutics, Inc. Call Options Transaction History

Magnus Financial Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 10, 2022	SELL	$2.26 - $3.34 $108,479 - $160,320	-48,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.35 - $3.88 $18,800 - $31,040	8,000 Added 20.0%	48,000 $22,000
Q2 2021 Aug 06, 2021	BUY	$2.83 - $4.2 $56,600 - $84,000	20,000 Added 100.0%	40,000 $4,000
Q1 2021 May 05, 2021	SELL	$2.92 - $5.06 $93,440 - $161,920	-32,000 Reduced 61.54%	20,000 $10,000
Q4 2020 Feb 05, 2021	BUY	$2.22 - $3.78 $40,848 - $69,552	18,400 Added 54.76%	52,000 $2,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $13.08 $80,304 - $439,488	33,600 New	33,600 $15,000

120

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.